雅培 ABT 深 滬
等待開盤 11-17 09:30:00 美东时间
130.59
+1.330
+1.03%
華盛通- 最 高130.96
- 今 開129.285
- 成交量 699.90万股
- 最 低 128.77
- 昨 收 129.26
- 總市值 2272.27亿
- 52周最高 139.46
- 市盈率 靜 17.10
- 換手率 0.00%
- 52周最低 108.92
- 委 比 -33.12%
- 總股本 17.40亿
- 歷史最高 139.46
- 量 比 1.39
- 振 幅 1.69%
- 歷史最低 14.24
- 每 手 1
- 風險率 7.46%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多What Does the Market Think About Abbott Laboratories?
Abbott Laboratories's (NYSE:ABT) short interest as a percent of float has risen...
11-14 23:00
Invesco Diversified Dividend Fund adds Abbott in Q3, sells Procter & Gamble
Invesco Diversified Dividend Fund delivered a positive return for the third quarter, but underperformed the Russell 1000 Value Index. Abbott Laboratories (ABT), Dupont (DD), Marsh & McLennan (MMC), a...
11-13 02:33
雅培携全程医学营养亮相进博会 精准营养助康复
（来源：中华工商网） 转自：中华工商网 【记者宋寒业上海报道】在本届进博会期间，雅培携全程医学营养解决方案亮相，展示医学营养领域的最新成果。同期，雅培还举办...
11-10 21:11
The Insider Report: The Bears Have Been Poked – Will They Fall Back Asleep?
Market Overview Stocks dropped hard last week, but a late-day rally on Friday s...
11-10 20:46
首展到应用，雅培无导线起搏技术体现进博会溢出效应
转自：贝壳财经 新京报讯（记者王卡拉）在第八届中国国际进口博览会（简称“进博会”）上，雅培携无导线起搏器再度亮相进博会医疗器械与医药保健展区。作为世界上首个且目...
11-10 15:01
起搏新技术为心律失常个性化治疗“铺路”
缓慢性心律失常是一种常见且严重的心脏疾病。目前，我国约有124万患者，65岁以上老年群体的患病率尤为突出。该疾病会导致心脏泵血功能不足，患者常表现为气喘、乏力等...
11-10 14:53
Cadrenal Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Cadrenal Therapeutics reported its financial results for Q3 2025, highlighting progress in clinical development of tecarfarin and acquisition of frunexian. The company completed tecarfarin manufacturing under cGMP and advances its Phase 2 studies in LVAD and dialysis patients. Frunexian, a Phase 2-ready IV Factor XIa inhibitor, targets acute care settings. cadrenal's net loss for the quarter was $2.7M, with cash reserves of $3.9M. The company emp...
11-10 14:00
Aligos Therapeutics Presents Positive Data at The Liver Meeting® 2025
Aligos Therapeutics announced positive data for pevifoscorvir sodium at the AASLD 2025 meeting, highlighting its best-in-class potential for treating chronic hepatitis B. The oral and poster presentations showed sustained viral suppression, with 75% of HBeAg+ and 100% of HBeAg- subjects maintaining HBV DNA below the lower limit of quantification during NA monotherapy. Pevifoscorvir sodium's ability to reduce HBV antigen and RNA levels, along with...
11-10 13:00
两亿多老人的“蛋糕”怎么分？有人拼速度有人做定制有人换战略
（来源：上观新闻） 65岁及以上人口占比在14%至20%，中国已是深度老龄化社会。 根据《2023年度国家老龄事业发展公报》，截至...
11-10 07:02
公司簡介
公司名稱
|
雅培
|
行業分類
|
医疗设备
|
業務描述
|
雅培致力于帮助人们通过健康拥有美好生活。125年多来，雅培不断创新，探索改善健康的解决方案——从营养品、诊断、医疗器械到药品——雅培为人生每个阶段创造更多可能。雅培全球94000多名员工，助力世界150多个国家和地区的人们获得健康精彩人生。雅培在中国运营近30年，总部位于上海，目前拥有超过4000多名员工。
|
What Does the Market Think About Abbott Laboratories?
Abbott Laboratories's (NYSE:ABT) short interest as a percent of float has risen...
11-14 23:00
Invesco Diversified Dividend Fund adds Abbott in Q3, sells Procter & Gamble
Invesco Diversified Dividend Fund delivered a positive return for the third quarter, but underperformed the Russell 1000 Value Index. Abbott Laboratories (ABT), Dupont (DD), Marsh & McLennan (MMC), a...
11-13 02:33
雅培携全程医学营养亮相进博会 精准营养助康复
（来源：中华工商网） 转自：中华工商网 【记者宋寒业上海报道】在本届进博会期间，雅培携全程医学营养解决方案亮相，展示医学营养领域的最新成果。同期，雅培还举办...
11-10 21:11
The Insider Report: The Bears Have Been Poked – Will They Fall Back Asleep?
Market Overview Stocks dropped hard last week, but a late-day rally on Friday s...
11-10 20:46
首展到应用，雅培无导线起搏技术体现进博会溢出效应
转自：贝壳财经 新京报讯（记者王卡拉）在第八届中国国际进口博览会（简称“进博会”）上，雅培携无导线起搏器再度亮相进博会医疗器械与医药保健展区。作为世界上首个且目...
11-10 15:01
起搏新技术为心律失常个性化治疗“铺路”
缓慢性心律失常是一种常见且严重的心脏疾病。目前，我国约有124万患者，65岁以上老年群体的患病率尤为突出。该疾病会导致心脏泵血功能不足，患者常表现为气喘、乏力等...
11-10 14:53
Cadrenal Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Cadrenal Therapeutics reported its financial results for Q3 2025, highlighting progress in clinical development of tecarfarin and acquisition of frunexian. The company completed tecarfarin manufacturing under cGMP and advances its Phase 2 studies in LVAD and dialysis patients. Frunexian, a Phase 2-ready IV Factor XIa inhibitor, targets acute care settings. cadrenal's net loss for the quarter was $2.7M, with cash reserves of $3.9M. The company emp...
11-10 14:00
Aligos Therapeutics Presents Positive Data at The Liver Meeting® 2025
Aligos Therapeutics announced positive data for pevifoscorvir sodium at the AASLD 2025 meeting, highlighting its best-in-class potential for treating chronic hepatitis B. The oral and poster presentations showed sustained viral suppression, with 75% of HBeAg+ and 100% of HBeAg- subjects maintaining HBV DNA below the lower limit of quantification during NA monotherapy. Pevifoscorvir sodium's ability to reduce HBV antigen and RNA levels, along with...
11-10 13:00
两亿多老人的“蛋糕”怎么分？有人拼速度有人做定制有人换战略
（来源：上观新闻） 65岁及以上人口占比在14%至20%，中国已是深度老龄化社会。 根据《2023年度国家老龄事业发展公报》，截至...
11-10 07:02
派息除權日
|
每股總股息
| 派息日期 |
2025-10-15
|
0.59
|
2025-11-17
|
2025-07-15
|
0.59
|
2025-08-15
|
2025-04-15
|
0.59
|
2025-05-15
|
2025-01-15
|
0.59
|
2025-02-14
|
2024-10-15
|
0.55
|
2024-11-15
|
2024-07-15
|
0.55
|
2024-08-15
|
2024-04-12
|
0.55
|
2024-05-15
|
2024-01-11
|
0.55
|
2024-02-15
|
2023-10-12
|
0.51
|
2023-11-15
|
2023-07-13
|
0.51
|
2023-08-15
|
2023-04-13
|
0.51
|
2023-05-15
|
2023-01-12
|
0.51
|
2023-02-15
|
2022-10-13
|
0.47
|
2022-11-15
|
2022-07-14
|
0.47
|
2022-08-15
|
2022-04-13
|
0.47
|
2022-05-16
|
2022-01-13
|
0.47
|
2022-02-15
|
2021-10-14
|
0.45
|
2021-11-15
|
2021-07-14
|
0.45
|
2021-08-16
|
2021-04-14
|
0.45
|
2021-05-17
|
2021-01-14
|
0.45
|
2021-02-16
|
2020-10-14
|
0.36
|
2020-11-16
|
2020-07-14
|
0.36
|
2020-08-17
|
2020-04-14
|
0.36
|
2020-05-15
|
2020-01-14
|
0.36
|
2020-02-14
|
2019-10-11
|
0.32
|
2019-11-15
|
2019-07-12
|
0.32
|
2019-08-15
|
2019-04-12
|
0.32
|
2019-05-15
|
2019-01-14
|
0.32
|
2019-02-15
|
2018-10-12
|
0.28
|
2018-11-15
|
2018-07-12
|
0.28
|
2018-08-15
|
2018-04-12
|
0.28
|
2018-05-15
|
2018-01-11
|
0.28
|
2018-02-15
|
2017-10-12
|
0.26
|
2017-11-15
|
2017-07-12
|
0.26
|
2017-08-15
|
2017-04-11
|
0.26
|
2017-05-15
|
2017-01-11
|
0.26
|
2017-02-15
|
2016-10-12
|
0.26
|
2016-11-15
|
2016-07-13
|
0.26
|
2016-08-15
|
2016-04-13
|
0.26
|
2016-05-16
|
2016-01-13
|
0.26
|
2016-02-16
|
2015-10-13
|
0.24
|
2015-11-15
|
2015-07-13
|
0.24
|
2015-08-15
|
2015-04-13
|
0.24
|
2015-05-15
|
2015-01-13
|
0.24
|
2015-02-13
|
2014-10-10
|
0.22
|
2014-11-15
|
2014-07-11
|
0.22
|
2014-08-15
|
2014-04-11
|
0.22
|
2014-05-15
|
2014-01-13
|
0.22
|
2014-02-15
|
2013-10-10
|
0.14
|
2013-11-15
|
2013-07-11
|
0.14
|
2013-08-15
|
2013-04-11
|
0.14
|
2013-05-15
|
2013-01-11
|
0.14
|
2013-02-15
|
2012-10-11
|
0.51
|
2012-11-15
|
2012-07-11
|
0.51
|
2012-08-15
|
2012-04-11
|
0.51
|
2012-05-15
|
2012-01-11
|
0.48
|
2012-02-15
|
2011-10-12
|
0.48
|
2011-11-15
|
2011-07-13
|
0.48
|
2011-08-15
|
2011-04-13
|
0.48
|
2011-05-16
|
2011-01-12
|
0.44
|
2011-02-15
|
2010-10-13
|
0.44
|
2010-11-15
|
2010-07-13
|
0.44
|
2010-08-15
|
2010-04-13
|
0.44
|
2010-05-15
|
2010-01-13
|
0.40
|
2010-02-15
|
2009-10-13
|
0.40
|
2009-11-15
|
2009-07-13
|
0.40
|
2009-08-15
|
2009-04-13
|
0.40
|
2009-05-15
|
2009-01-13
|
0.36
|
2009-02-15
|
2008-10-10
|
0.36
|
2008-11-15
|
2008-07-11
|
0.36
|
2008-08-15
|
2008-04-11
|
0.36
|
2008-05-15
|
2008-01-11
|
0.32
|
2008-02-15
|
2007-10-11
|
0.32
|
2007-11-15
|
2007-07-11
|
0.32
|
2007-08-15
|
2007-04-11
|
0.32
|
2007-05-15
|
2007-01-10
|
0.29
|
2007-02-15
|
2006-10-11
|
0.29
|
2006-11-15
|
2006-07-12
|
0.29
|
2006-08-15
|
2006-04-11
|
0.29
|
2006-05-15
|
2006-01-11
|
0.28
|
2006-02-15
|
2005-10-12
|
0.28
|
2005-11-15
|
2005-07-13
|
0.28
|
2005-08-15
|
2005-04-13
|
0.28
|
2005-05-15
|
2005-01-12
|
0.26
|
2005-02-15
|
2004-10-13
|
0.26
|
2004-11-15
|
2004-07-13
|
0.26
|
2004-08-15
|
2004-04-13
|
0.26
|
2004-05-15
|
2004-01-13
|
0.25
|
2004-02-15
|
2003-10-10
|
0.25
|
2003-11-15
|
2003-07-11
|
0.25
|
2003-08-15
|
2003-04-11
|
0.25
|
2003-05-15
|
2003-01-13
|
0.23
|
2003-02-15
|
2002-10-10
|
0.23
|
2002-11-15
|
2002-07-11
|
0.23
|
2002-08-15
|
2002-04-11
|
0.23
|
2002-05-15
|
2002-01-11
|
0.21
|
2002-02-15
|
2001-10-11
|
0.21
|
2001-11-15
|
2001-07-11
|
0.21
|
2001-08-15
|
2001-04-10
|
0.21
|
2001-05-15
|
2001-01-10
|
0.19
|
2001-02-15
|
2000-10-11
|
0.19
|
2000-11-15
|
2000-07-12
|
0.19
|
2000-08-15
|
2000-04-12
|
0.19
|
2000-05-15
|
2000-01-12
|
0.17
|
2000-02-15
|
1999-10-13
|
0.17
|
1999-11-15
|
1999-07-13
|
0.17
|
1999-08-15
|
1999-04-13
|
0.17
|
1999-05-15
|
1999-01-13
|
0.15
|
1999-02-15
|
1998-10-13
|
0.15
|
1998-11-15
|
1998-07-13
|
0.15
|
1998-08-15
|
1998-04-13
|
0.30
|
1998-05-15
|
1998-01-13
|
0.27
|
1998-02-15
|
1997-10-10
|
0.27
|
1997-11-15
|
1997-07-11
|
0.27
|
1997-08-15
|
1997-04-11
|
0.27
|
1997-05-15
|
1997-01-13
|
0.24
|
1997-02-15
|
1996-10-10
|
0.24
|
1996-11-15
|
1996-07-11
|
0.24
|
1996-08-15
|
1996-04-11
|
0.24
|
1996-05-15
|
1996-01-10
|
0.21
|
1996-02-15
|
1995-10-11
|
0.21
|
1995-11-15
|
1995-07-12
|
0.21
|
1995-08-15
|
1995-04-07
|
0.21
|
1995-05-15
|
1995-01-09
|
0.19
|
1995-02-15
|
1994-10-07
|
0.19
|
1994-11-15
|
1994-07-11
|
0.19
|
1994-08-15
|
1994-04-11
|
0.19
|
1994-05-15
|
1994-01-10
|
0.17
|
1994-02-15
|
1993-10-08
|
0.17
|
1993-11-15
|
1993-07-09
|
0.17
|
1993-08-15
|
1993-04-08
|
0.17
|
1993-05-15
|
1993-01-11
|
0.15
|
1993-02-15
|
1992-10-08
|
0.15
|
1992-11-15
|
1992-07-09
|
0.15
|
1992-08-15
|
1992-04-09
|
0.30
|
1992-05-15
|
1992-01-09
|
0.25
|
1992-02-15
|
1991-10-08
|
0.25
|
1991-11-15
|
1991-07-09
|
0.25
|
1991-08-15
|
1991-04-09
|
0.25
|
1991-05-15
|
1991-01-09
|
0.21
|
1991-02-15
|
1990-10-09
|
0.21
|
1990-11-15
|
1990-07-09
|
0.21
|
1990-08-15
|
1990-04-06
|
0.42
|
1990-05-15
|
1990-01-08
|
0.35
|
1990-02-15
|
1989-10-06
|
0.35
|
1989-11-15
|
1989-07-10
|
0.35
|
1989-08-15
|
1989-04-10
|
0.35
|
1989-05-15
|
1989-01-09
|
0.30
|
1989-02-15
|
1988-10-07
|
0.30
|
1988-11-15
|
1988-07-11
|
0.30
|
1988-08-15
|
1988-04-10
|
0.30
|
1988-05-15
|
1988-01-11
|
0.25
|
1988-02-15
|
1987-10-08
|
0.25
|
1987-11-16
|
1987-07-09
|
0.25
|
1987-08-15
|
1987-04-09
|
0.25
|
1987-05-15
|
1987-01-09
|
0.21
|
1987-02-15
|
1986-10-08
|
0.21
|
1986-11-15
|
1986-07-09
|
0.21
|
1986-08-15
|
1986-04-09
|
0.42
|
1986-05-15
|
1986-01-10
|
0.35
|
1986-02-15
|
1985-10-08
|
0.35
|
1985-11-15
|
1985-07-09
|
0.35
|
1985-08-15
|
1985-04-09
|
0.35
|
1985-05-15
|
1985-01-09
|
0.30
|
1985-02-15
|
1984-10-09
|
0.30
|
1984-11-15
|
1984-07-09
|
0.30
|
1984-08-15
|
1984-04-09
|
0.30
|
1984-05-15
|
1984-01-09
|
0.25
|
1984-02-15
|
1983-10-07
|
0.25
|
1983-11-15
|
1983-07-11
|
0.25
|
1983-08-15
|
1983-04-11
|
0.25
|
1983-05-15
|
1983-01-10
|
0.21
|
1983-02-15
|
1982-10-08
|
0.21
|
1982-11-15
|
1982-07-12
|
0.21
|
1982-08-15
|
1982-04-12
|
0.21
|
1982-05-15
|
1982-01-11
|
0.18
|
1982-02-15
|
1981-10-09
|
0.18
|
1981-11-15
|
1981-07-13
|
0.18
|
1981-08-15
|
1981-04-10
|
0.36
|
1981-05-15
|
1981-01-12
|
0.30
|
1981-02-15
|
1980-10-10
|
0.30
|
1980-11-15
|
1980-07-14
|
0.30
|
1980-08-15
|
1980-04-13
|
0.30
|
1980-05-15
|
1980-01-13
|
0.25
|
1980-02-14
|
1979-10-04
|
0.25
|
1979-11-14
|
1979-07-08
|
0.25
|
1979-08-14
|
1979-04-15
|
0.25
|
1979-05-14
|
1979-01-07
|
0.21
|
1979-02-14
|
1978-10-05
|
0.21
|
1978-11-14
|
1978-07-09
|
0.18
|
1978-08-14
|
1978-04-09
|
0.36
|
1978-05-14
|
1978-01-08
|
0.30
|
1978-02-14
|
1977-10-06
|
0.30
|
1977-11-14
|
1977-07-10
|
0.30
|
1977-08-14
|
1977-04-10
|
0.25
|
1977-05-14
|
